Apexus Wins HRSA Contract to Remain Prime Vendor of 340B Program

Texas-Based Company Will Continue to Assist Safety-Net Providers in Providing Care to More Patients

September 29, 2014

Apexus, LLC, the prime vendor for the 340B Drug Pricing Program, has announced that it has been selected by the Health Resources and Services Administration (HRSA) to continue serving in its role as the prime vendor through September 29, 2019. Apexus, which has held this position for the past 10 years, will continue to work with more than 25,000 safety-net provider locations, drug manufacturers, pharmacy wholesalers, and other stakeholders to negotiate discounts on pharmaceuticals and offer valued services, while supporting compliant operations and helping stakeholders to continue to deliver health care services to underserved populations.

“We are thrilled and proud for the opportunity to continue working with HRSA to strengthen this important program that helps so many families across the nation gain access to essential medications,” said Apexus President Chris Hatwig. “With our team’s unsurpassed knowledge of the 340B Program, our unique national distribution channels, and our highly regarded educational programs, we are able to deliver maximum value to 340B stakeholders through the promotion of program integrity, compliance, and optimization of the program.”

Beyond its contract work, Apexus is also the premier national resource for 340B educational programs, helping 340B stakeholders and healthcare policy experts receive and understand the latest information about the 340B program. Apexus Answers, its national call center, aligns with HRSA to provide up-to-date policy, compliance, registration, and recertification information.

The 340B Program was signed into law by President George H.W. Bush in 1992 with the purpose of requiring drug manufacturers to provide outpatient drugs to eligible hospitals, clinics, and other health care organizations at significantly reduced prices so these covered entities could stretch their resources and be able to provide medications and other services to underserved populations.

Apexus serves as the exclusive prime vendor for the 340B Program, managed by the Health Resources and Services Administration (HRSA). As the 340B prime vendor, Apexus works closely with HRSA’s Office of Pharmacy Affairs to enable approved entities to optimize the value of the 340B drug pricing by both reducing costs and supporting entities to establish compliant operations in the communities they serve. Apexus also operates Apexus Answers, the national call center available for all stakeholder questions, and manages in-depth 340B educational programs through 340B University™ to support stakeholder compliance and program integrity.

Based in Irving, Texas, Apexus currently serves more than 25,000 safety-net provider locations by delivering additional savings on pharmaceuticals through the 340B Prime Vendor Program (PVP).

 
Contact:
Lisa Sokol
(972) 910-6665